RAYMOND HERNANDEZ: Open Payments
NPI 1508396557 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 36 payments from 10 companies in 2025. Trend: 2023 $1,044 · 2024 $3,190 · 2025 $1,313
Food & beverage: $875Speaker / faculty: $438
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 2 | $452 |
| Novartis Pharmaceuticals Corporation | 10 | $222 |
| Incyte Corporation | 4 | $200 |
| AstraZeneca Pharmaceuticals LP | 9 | $187 |
| Daiichi Sankyo Inc. | 4 | $90 |
| ABBVIE INC. | 3 | $61 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| BeOne Medicines USA, Inc. | 1 | $28 |
| BeiGene USA, Inc. | 1 | $27 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
Products named: BESREMI, SCEMBLIX, CALQUENCE, Niktimvo, Vanflyta, BRUKINSA, JAKAFI, VENCLEXTA.
Industry payments across CA — which companies pay providers there.
